Background: Eclampsia is a hypertensive disorder related to pregnancy, in which there is occurrence of one or more generalized convulsions and or coma, in the absence of other neurologic conditions. It is a common obstetric emergency. It contributes significantly to maternal and perinatal morbidity and mortality. Dr. J. A. Pritchard in 1955, introduced magnesium sulphate for control of convulsions in eclampsia and is used worldwide. Considering the low body mass index of Indian women, a low dose magnesium sulphate regime has been introduced by some authors. The Objective was to compare the efficacy of low dose magnesium sulphate regimen with standard Pritchard"s regimen for eclampsia. Methods: A prospective randomized study of fifty eclampsia cases, treated with magnesium sulphate (25 each with low dose regime and Pritchard regime) was carried out from October 2010 to January 2012 at MAMC & LNH, New Delhi, India. Results were analysed using Statistical Package of Social Sciences (SPSS) software 17.0. Results: In the present study, convulsions were controlled in 96% of eclampsia cases with low dose magnesium sulphate regimen. One case i.e. 4% had single episode of recurrence of convulsion, which was controlled by giving additional drugs and shifted to standard dose regimen. There was no maternal mortality. Conclusions: The maternal and perinatal morbidity and mortality in the present study were comparable to those of standard Pritchard"s regimen. The study did not find a single case of magnesium related toxicity with low dose magnesium sulphate regimen. Low dose magnesium sulphate regimen was found to be safe and effective in eclampsia.
The positive psychological effects of improving patients' smile often contribute to an improved self-image and enhanced self-esteem. Periodontal disease may lead to tooth and tissue loss that can result in esthetic problems. Combined periodontal/prosthodontic treatment for patients with advanced disease is well documented. This case report illustrates a method of treatment for an advanced tissue loss in an esthetic area using a removable silicone gingival prosthesis/mask.
Hand deformities affects function and esthetics. Moreover, for the majority of patients, the loss of a finger can lead to psychological problems. This report describes the fabrication of a silicone finger prosthesis for a patient after an accident. The finger prosthesis was retained by a vacuum effect on the stump. The room temperature vulcanizing (RTV) silicone material was used to provide function and esthetics. The finger prosthesis offered psychological, functional, and rehabilitative advantages for the patient.
How to cite this article
Tomar BS, Chandu GS, Singh S, Sapat M, Khatri M, Jain P. Concealment of Amputation: Silicone Finger Prosthesis. Int J Experiment Dent Sci 2016;5(2):146-150.
Gingival recession is defined as the displacement of gingival margin apical to cementoenamel junction. Aberrant frenum attachment can contribute to the progression of recession by generating tension on the marginal tissues. Treating such defects is a two stage procedure-frenectomy and recession coverage procedure. New techniques are developed to increase the predictability, reduce patient discomfort and number of surgical sites. Also, these techniques try to satisfy patients esthetic demands, which include the final colour and tissue blend of the covered area. In this case report, we present a method for coronally repositioning gingiva for root coverage over the maxillary central incisors while simultaneously performing a frenectomy, thus being clinically advantageous compared to two-stage technique.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.